logo
Select company
Select metric
$ -38.35MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
15
Sector
39
Industry
24
History
100
$ 1.3Close
$ 0.55 - $ 2.2 52-Week Range
Ticker Information

Ticker

HYPR

Company Name

HYPERFINE INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

HYPERFINE INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HYPR - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 1M$ -39.36M$ -38.35M
3/31/2025$ 975K$ -40.29M$ -39.31M
12/31/2024$ 1.01M$ -40.72M$ -39.71M
9/30/2024$ 1.04M$ -41.01M$ -39.98M
6/30/2024$ 1.06M$ -41.45M$ -40.39M
3/31/2024$ 1.06M$ -41.93M$ -40.86M
12/31/2023$ 1.05M$ -44.24M$ -43.18M
9/30/2023$ 1.05M$ -46.61M$ -45.56M
6/30/2023$ 1.01M$ -49.03M$ -48.02M
3/31/2023$ 1.02M$ -61.55M$ -60.53M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HYPERFINE INC's latest trailing twelve months (TTM) EBITDA stands at $ 0.
  • Over the past 5 years, HYPERFINE INC's average EBITDA has been $ -56.92M.
  • The median EBITDA for HYPERFINE INC during this period was $ -45.56M
  • HYPERFINE INC reached its highest EBITDA over the past 5 years at $ -38.35M.
  • The lowest EBITDA recorded by HYPERFINE INC in the same timeframe $ -108.96M

HYPERFINE INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
NSPR : INSPIREMD INC $ -40.97MLUCD : LUCID DIAGNOSTICS INC $ -54.36MNMTC : NEUROONE MEDICAL TECHNOLOGIES CORP $ -4.97MSRZN : SURROZEN INC $ -31.83MFATE : FATE THERAPEUTICS INC $ -155.49MPROF : PROFOUND MEDICAL CORP $ -33.01MCRVO : CERVOMED INC $ -22.61MTCRX : TSCAN THERAPEUTICS INC $ -130.55MVVOS : VIVOS THERAPEUTICS INC $ -13.55MNVNO : ENVVENO MEDICAL CORP $ -22.57M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for HYPERFINE INC is calculated as follows: EBIT [ $ -2.49M ] + DepAmor [ $ 0 ]
(=) EBITDA [ $ 0 ]

HYPR - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -108.96M

Minimum

Jun 30, 2022

$ -38.35M

Maximum

Jun 30, 2025

$ -56.92M

Average

$ -45.56M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M